Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01855802
Recruitment Status : Completed
First Posted : May 17, 2013
Last Update Posted : January 18, 2017
Sponsor:
Information provided by (Responsible Party):
Georgios Labiris, Democritus University of Thrace

Brief Summary:
This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire.

Condition or disease
Glaucoma

Detailed Description:

The following dimensions will be recorded

  1. Overall physician's empathy regarding generics in glaucoma
  2. Physician's prescribing habits regarding generics in glaucoma
  3. Physician's perceptions regarding generics cost-effectiveness in glaucoma
  4. Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma)
  5. Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)

Layout table for study information
Study Type : Observational
Actual Enrollment : 70 participants
Official Title: Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma
Study Start Date : April 2013
Actual Primary Completion Date : September 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma




Primary Outcome Measures :
  1. Generic Perception [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 67 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Greek Medical Council Members
Criteria

Inclusion Criteria:

Licensed Registration to Greek Ophthalmology Council

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01855802


Locations
Layout table for location information
Greece
University Hospital of Alexandroupolis
Alexandroupolis, Evros, Greece, 68100
Sponsors and Collaborators
Democritus University of Thrace
Investigators
Layout table for investigator information
Principal Investigator: Georgios Labiris, PhD Democritus University of Thrace, Medical School

Publications of Results:
Layout table for additonal information
Responsible Party: Georgios Labiris, Assistant Professor, Democritus University of Thrace
ClinicalTrials.gov Identifier: NCT01855802     History of Changes
Other Study ID Numbers: EIT-GG-P
First Posted: May 17, 2013    Key Record Dates
Last Update Posted: January 18, 2017
Last Verified: January 2017

Keywords provided by Georgios Labiris, Democritus University of Thrace:
Greece
Ophthalmology
Glaucoma
Generics
Perception

Additional relevant MeSH terms:
Layout table for MeSH terms
Glaucoma
Ocular Hypertension
Eye Diseases